PharmaBoardroom’s Top Patient Group Insights 2021
PharmaBoardroom has spoken to leaders from several important global patient advocacy organisations in 2021 who shared their concerns on crucial global…
Tagged with HTA
CADTH CEO Suzanne McGurn on the Key Challenges in HTA Today
In conversation in the October edition of DIA’s Global Forum magazine, Canadian Agency for Drugs and Technologies in Health (CADTH) CEO Suzanne…
Denmark: Data Crucial To Innovative Access Agreements
Established in 2017, the Danish Medicines Council is the health technology assessment (HTA)-like body in Denmark which assesses the value for patients…
Jørgen Schøler Kristensen – Chairman, Danish Medicines…
Jørgen Schøler Kristensen explains the role of the Danish Medicines Council, providing guidance about new medicines for use in the Danish hospital…
Health Technology Assessment in the EU: Back and Forth in Giant…
Writing in the August edition of DIA's Global Forum, Sanofi R&D's Thomas Kühler outlines the bumpy journey towards the full adoption of Health…
EUnetHTA’s Uncertain Future & the Evolution of…
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the establishment of a sustainable European…
Niklas Hedberg – Chair of the Executive Board, EUnetHTA;…
Niklas Hedberg outlines the role of EUnetHTA as both a network and project built up of national HTAs in Europe, the potential for a continent-wide…
Putting People Ahead of the Maths: Addressing the Limitations of…
Mike Glover, Vice President Global Head of Access and Pricing Strategy Oncology at GSK outlines that while new mathematical approaches to health…
Francis Arickx – Country Coordinator Belgium, Beneluxa
Francis Arickx, country coordinator of Belgium for the Beneluxa Initiative, introduces the project and its mission to help shape a unified healthcare…
Tomáš Dolezal – President, Czech Regional Chapter,…
Tomáš Dolezal, president of the International Society for Pharmacoeconomics and Outcomes (ISPOR) Czech Regional Chapter and director of the…
Niklas Hedberg – Chair of the Executive Board, EUnetHTA
Niklas Hedberg is both chair of EUnetHTA Executive Board (a branch of the European Commission) and chief pharmacist at the Swedish Dental and…
A New Assessment Procedure for Reimbursable Medicines in…
Ruta Pumputiene examines recent regulatory reform in Lithuania, as the Baltic nation attempts to introduce a holistic HTA mechanism for the evaluation…
